Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2011-06-14
2011-06-14
Ward, Paul V. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C540S145000
Reexamination Certificate
active
07960371
ABSTRACT:
Large scale (bulk) compositions comprising high-purity stannsoporfin are disclosed, as well as methods of synthesizing such compositions.
REFERENCES:
patent: 4619923 (1986-10-01), Kappas et al.
patent: 4657902 (1987-04-01), Kappas et al.
patent: 4668670 (1987-05-01), Rideout et al.
patent: 4684637 (1987-08-01), Kappas et al.
patent: 4692439 (1987-09-01), Rideout et al.
patent: 4692440 (1987-09-01), Kappas et al.
patent: 4708964 (1987-11-01), Allen
patent: 4782049 (1988-11-01), Kappas et al.
patent: 4831024 (1989-05-01), Vreman et al.
patent: 4861876 (1989-08-01), Kessel
patent: 4900871 (1990-02-01), Ellis, Jr. et al.
patent: 5010073 (1991-04-01), Kappas et al.
patent: 5062775 (1991-11-01), Orth
patent: 5081115 (1992-01-01), Vreman et al.
patent: 5162313 (1992-11-01), Kappas et al.
patent: 5192757 (1993-03-01), Johnson et al.
patent: 5223494 (1993-06-01), Kappas et al.
patent: 5275801 (1994-01-01), Niedballa et al.
patent: 5371199 (1994-12-01), Therien et al.
patent: 5493017 (1996-02-01), Therien et al.
patent: 5817830 (1998-10-01), Therien et al.
patent: 5883246 (1999-03-01), Brückner et al.
patent: 5886173 (1999-03-01), Hemmi et al.
patent: 5889181 (1999-03-01), Kudrevich et al.
patent: 5912341 (1999-06-01), Hoffman et al.
patent: 5929064 (1999-07-01), Goel et al.
patent: 5955603 (1999-09-01), Therien et al.
patent: 5973141 (1999-10-01), Robinson et al.
patent: 5990363 (1999-11-01), Wijesekera et al.
patent: 6004530 (1999-12-01), Sagner et al.
patent: 6066333 (2000-05-01), Willis et al.
patent: 6114321 (2000-09-01), Platzek et al.
patent: 6124452 (2000-09-01), DiMagno
patent: 6177561 (2001-01-01), Sinn et al.
patent: 6194566 (2001-02-01), Platzek et al.
patent: 6235895 (2001-05-01), McEwan et al.
patent: 6420553 (2002-07-01), Inoue et al.
patent: 6462192 (2002-10-01), Robinson et al.
patent: 6818763 (2004-11-01), Vukovich et al.
patent: 7375216 (2008-05-01), Vukovich et al.
patent: 2003/0100752 (2003-05-01), Robinson
patent: 2003/0225264 (2003-12-01), Vukovich et al.
patent: 2004/0097481 (2004-05-01), Levinson et al.
patent: 2004/0210048 (2004-10-01), Vukovich et al.
patent: 2006/0222668 (2006-10-01), Drummond et al.
patent: 2006/0222669 (2006-10-01), Drummond et al.
patent: 2008/0113955 (2008-05-01), Levinson et al.
patent: 2008/0154033 (2008-06-01), Vukovich et al.
patent: 2008/0261939 (2008-10-01), Drummond et al.
patent: 2448570 (2002-12-01), None
patent: 0199888 (1986-11-01), None
patent: 58-501130 (1983-07-01), None
patent: 1-501627 (1989-08-01), None
patent: WO-89/02269 (1989-03-01), None
patent: WO 91/04667 (1991-04-01), None
patent: WO-94/28906 (1994-12-01), None
patent: WO 97/05152 (1997-02-01), None
patent: WO 01/68099 (2001-09-01), None
patent: WO-03/101999 (2003-12-01), None
patent: WO-03/101999 (2003-12-01), None
patent: WO2004-045546 (2004-06-01), None
patent: WO-2004/045546 (2004-06-01), None
patent: WO-2004/045546 (2004-06-01), None
patent: WO-2005/103056 (2005-11-01), None
patent: WO-2005/103056 (2005-11-01), None
patent: WO 2006/107806 (2006-10-01), None
patent: WO 2006/107806 (2006-10-01), None
patent: WO 2008/045377 (2008-04-01), None
patent: WO 2008/045377 (2008-04-01), None
patent: WO 2008/045378 (2008-04-01), None
patent: WO 2008/045378 (2008-04-01), None
Baker, E.W. et al. (Aug. 1964). “The Preparation of Mesoporphyrin IX and Etioporphyrin III,”Analytical Biochemistry8(4):512-518.
Bauer, J. et al. (1988). “Stability-Indicating High Performance Liquid Chromatographic Analysis of Tin Protoporphyrin and Other Free Acid Metalloporphyrins,”Journal of Chromatography445:429-432.
Cowan, J.A. et al. (May 31, 1989). “Synthesis and Properties of Metal-Substituted Myoglobins,”Inorganic Chemistry28(11):2074-2078.
Delaney, J.K. et al. (Apr. 1988). “Photophysical Properties of Sn-Porphyrins: Potential Clinical Implications,”Pediatrics81(4):498-504.
Ellfolk, N. et al. (1969). “Separation of Porphyrins by Multiple Liquid-Liquid Partition,”Acta. Chem. Scand. 23(3 part I):846-858.
Kappas, A. et al. (Apr. 1995). “Direct Comparison of Sn-Mesoporphyrin, An Inhibitor of Bilirubin Production, and Phototherapy in Controlling Hyperbilirubinemia in Term and Near-Term Newborns,”Pediatrics95(4):468-474.
Sugihara, J.M. et al. (Nov. 1964). “Determination of Vanadyl Porphyrins by Demetalation with Hydrogen Bromide-Formic Acid,”Analytical Chemistry36(12):2374-2376.
Taylor, J.F. (Sep. 1, 1940). “Metalloporphyrins. II. Cobalt and Manganese Mesoporphyrins in Coordination with Nitrogenous Bases,”Journal of Biological Chemistry135(2):569-595.
U.S Appl. No. 11/867,581, filed Oct. 4, 2007, by Drummond et al. (not attached).
Valaes, T. et al. (Jan. 1994). “Control of Jaundice in Preterm Newborns by an Inhibitor of Bilirubin Production: Studies With Tin-Mesoporphyrin,” Pediatrics 93(1):1-11.
Bauer et al. “Pharmazeutische Technologie” 1993published by George Thieme Verlag Stuttgart(New York) 4th Ed. pp. 225-227.
Bettelheim et al. “Chapter 8. Proteins” 1998,General Organic&Biochemistry, 5thEd. p. 596.
Bhutani et al. “Randomized Placebo-Controlled Clinical Trial of Stannsoporfin (Sn-MP) to Prevent Severe Hyperbillirubinemia in Term and Near-Term Infants” Apr. 2004Pediatric ResearchAbstract No. 2542.
Breslow et al. “Biochemical Properties of the Heme Oxygenase Inhibitor, Sn-Protoporphyrin” Mar. 5, 1986,The Journal of Biological Chemistry261(7):3135-3141.
Corwin et al. “A Synthetic Ferroporphyrin Complex That Is Passive to Oxygen” Aug.-Dec. 1946Journal of the American Chemical Society68:2473-2478.
Drummond et al. “Reduction of the C2and C4Vinyl groups of Sn-Protoporphyrin to Form Sn-Mesoporphyrin Markedly Enhances the Ability of the Metalloporphyrin to Inhibit in Vivo Heme Catabolism” May 15, 1987,Archives of Biochemistry and Biophysics255(1):64-74.
Drummond et al. “An Experimental Model of Postnatal Jaundice in the Suckling Rat, Suppression of Induced Hyperbillirubinemia by Sn-Protoprophyrin” Jul. 1984,J. Clin. Invest. 74:142-149.
Drummond et al. “Prevention of neonatal hyperbillirubinemia by tin Protoporphyrin IX, a potent competitive inhibitor of heme oxidation” Oct. 1981,Proc. Natl. Acad. Sci. USA78(10):6466-6470.
Drummond et al. “Chemoprevention of Severe Neonatal Hyperbillirubinemia” Oct. 2004,Seminars in Perinatology28(5):365-368.
Drummond “Control of Heme Metabolism by Synthetic Metalloporphyrins” 1987,Annals of New York Academy of Sciences514:87-95.
Galbraith et al. “Pharmacokinetics of Tin-Mesoporphyrin in Man and the Effects of Tin-Chelated Porphyrins of Hyperexcretion of Heme Pathway Precursors in Patients with Acute Inducible Porphyria” Jun. 1989,Hepatology9(6):882-888.
Hamori et al. “Suppression of Carbon Monoxide Excretion by Zinc Mesoporphyrin in Adult Wistar Rats: Evidence for Potent in Vivo Inhibition of Billirubin Production” Oct. 1988,Research Communications in Chemical Pathology and Pharmacology62(1):41-48.
Hansen “Kernicterus in Term and Near-Term Infants—The Specter Walks Again” Oct. 2000, Acta Pediatrica 89(10):1155-1157.
International Search Report mailed May 26, 2004 for PCT Patent Application No. PCT/US 03/36885 filed Nov. 18, 2003, two pages.
International Search Report mailed Jun. 21, 2004 for PCT Patent Application No. PCT/US 03/17426 field Jun. 3, 2003, two pages.
International Search Report mailed Feb. 9, 2007 for PCT Patent Application No. PCT/US 04/39240 filed Nov. 24, 2004, two pages.
International Search Report mailed May 24, 2007 for PCT Application No. PCT/US 06/12185 filed Mar. 31, 2006, three pages.
International Search Report mailed Mar. 27, 2008 for PCT Patent Application No. PCT/US07/21485 filed Oct. 4, 2007, three pages.
International Search Report mailed Apr. 3, 2008 for PCT Patent Applicatoin No. PCT/US 07/021486 filed on Apr. 10, 2007, 5 pages.
Kaplan et al. “Determination of Isosmolar Blood Anticoagulant Solutions by the Fr
Boucher Christopher P.
Caroselli Robert
Cooke Keith A.
Drummond George S.
Levin Daniel
Infacare Pharmaceutical Corporation
Pepper Hamilton LLP
Ward Paul V.
LandOfFree
High-purity large-scale preparation of stannsoporfin does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with High-purity large-scale preparation of stannsoporfin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and High-purity large-scale preparation of stannsoporfin will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2711240